Search research articles
Contact Us
Filters
Showing results (391-400 of 602) with videos related to
Page
of 61
Sort By:
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
NPJ Parkinson'S Disease
|
March 16, 2024
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
Marina Peball, Beatrice Heim, Federico Carbone, et al.
Movement Disorders Clinical Practice
|
June 19, 2023
Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility-Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
Anna Grossauer, Christoph Müller, Anna Hussl, et al.
Journal of Parkinson'S Disease
|
June 7, 2021
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson's Disease: A Randomized, Placebo-Controlled, Phase 1 Study
Werner Poewe, Dieter Volc, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 30, 2012
Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?
Heike Stockner, Petra Schwingenschuh, Atbin Djamshidian, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 11, 2023
Reply to Letter to the Editor: "Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up"
Lars Lau Raket, Ingeborg Helbech Hansen, Line Kühnel, et al.
Parkinsonism & Related Disorders
|
December 3, 2020
Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism
Beatrice Heim, Stephanie Mangesius, Florian Krismer, et al.
The Lancet. Neurology
|
December 16, 2014
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial
Werner Poewe, Klaus Seppi, Cheryl J Fitzer-Attas, et al.
The Lancet. Neurology
|
July 30, 2018
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
Regina Katzenschlager, Werner Poewe, Olivier Rascol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 8, 2021
Impaired Inhibitory Control of Saccadic Eye Movements in Cervical Dystonia: An Eye-Tracking Study
Federico Carbone, Philipp Ellmerer, Marcel Ritter, et al.
Page
of 61
Search research articles
Search
Showing results (391-400 of 602) with videos related to
Sort By:
Page
of 61
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
NPJ Parkinson'S Disease
|
March 16, 2024
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
Marina Peball, Beatrice Heim, Federico Carbone, et al.
Movement Disorders Clinical Practice
|
June 19, 2023
Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility-Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
Anna Grossauer, Christoph Müller, Anna Hussl, et al.
Journal of Parkinson'S Disease
|
June 7, 2021
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson's Disease: A Randomized, Placebo-Controlled, Phase 1 Study
Werner Poewe, Dieter Volc, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 30, 2012
Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?
Heike Stockner, Petra Schwingenschuh, Atbin Djamshidian, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 11, 2023
Reply to Letter to the Editor: "Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up"
Lars Lau Raket, Ingeborg Helbech Hansen, Line Kühnel, et al.
Parkinsonism & Related Disorders
|
December 3, 2020
Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism
Beatrice Heim, Stephanie Mangesius, Florian Krismer, et al.
The Lancet. Neurology
|
December 16, 2014
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial
Werner Poewe, Klaus Seppi, Cheryl J Fitzer-Attas, et al.
The Lancet. Neurology
|
July 30, 2018
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
Regina Katzenschlager, Werner Poewe, Olivier Rascol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 8, 2021
Impaired Inhibitory Control of Saccadic Eye Movements in Cervical Dystonia: An Eye-Tracking Study
Federico Carbone, Philipp Ellmerer, Marcel Ritter, et al.
Page
of 61